Karreth et al. (2015) suggested that BRAF pseudogenes BRAF-RS1 and BRAFP1 functioned as ceRNAs to elevate BRAF expression and activate MAPK signaling, thereby eliciting their roles in lymphoma. This evidence concerns the gene BRAF and lymphoma.